Medtronic grows in Q4 but cardiac rhythm management and spine still a problem
This article was originally published in Clinica
Executive Summary
Medtronic has grown its top and bottom lines during its fourth fiscal quarter, in spite of a continuing lacklustre performance from its cardiac rhythm disease management and spinal businesses.